Prof. MD.

Mehmet Sayarlıoğlu

Rheumatology

Interests

  • Behcet's Disease
  • Rheumatoid arthritis
  • Psoriasis rheumatism
  • Spondylitis
  • Familial Mediterranean Fever
  • SLE (Lupus)
  • Sjögren's syndrome
  • Gout
  • Systemic sclerosis
  • Seronegative arthritis
  • Unclassifiable connective tissue diseases

Education:

  • Uludağ University / Faculty of Medicine / 1990
  • Istanbul Şişli Eftal Hospital Internal Diseases  Clinic / Exp. /1997
  • Istanbul University Faculty of Medicine /Internal Diseases Dept. Rheumatology/2001

Experience :

  • Malatya Public Hospital / 1990-1992
  • İstanbul Şişli Etfal Hospital, Internal Diseases Clinic / 1992-1997
  • Vakıf Gureba Training Hospital Internal Diseases Clinic /1997-1998
  • Yüzüncü Yıl University Faculty of Medicine / Internal Diseases Dept. /1998-1999
  • Istanbul Çapa Faculty of Medicine Rheumatology Dept. /2001-2005
  • Kahramanmaraş Sütçü Imam University Faculty of Medicine Internal Diseases Dept. Rheumatology Cl. /2005-2013
  • Ondokuz Mayıs University Faculty of Medicine Internal Diseases Dept. Rheumatology Cl/2013-2017

Undergraduate and graduate courses given in the last two years (2009-2017):

  • Introduction to rheumatology and rheumatological concepts
  • Differential diagnosis of acute and chronic arthritis
  • Differential diagnosis of monoarthritis / oligoarthritis / polyarthritis
  • Rheumatoid arthritis
  • SLE and antiphospholipid syndrome
  • Systemic vasculitis
  • Behcet 's disease
  • spondylarthritis
  • FMF
  • Inflammatory myositis
  • Mixed connective tissue diseases
  • Seronegative arthritis
  • Crystal arthropathies
  • Sjogren's syndrome
  • Systemic sclerosis
  • Articles Published in International Refereed Journals in SCI SSCI, AHC 1
  • Arslan H, Sakarya ME, Adak B, Unal O, Sayarlioglu M, ‘‘Duplex and color doppler sonographic findings in active sacroiliitis’’, Am J Roentgenol, 173, 677-680 (1999).
  • Guler N, Bilge M, Eryonucu B, Erkoc R, Sayarlioglu M, ‘‘Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction’’, Am J Cardiol, 85, 1391-93 (2000).
  • Sayarlioglu M, Sayarlioglu H, Ozen S, Erkoc R, Gul A. ‘‘Colchicine-induced myopathy in a teenager with familial Mediterranean fever’’, Ann Pharmacother, 37, 1821-24 (2003).
  • Harman M, Sayarlioglu M, Arslan H, Ayakta H, Harman E, ‘‘Fibrosing mediastinitis and thrombosis of superior vena cava associated with Behcet's disease’’, Eur J Radiol, 48, 209-12 (2003).
  • Kamali S, Gul A, Poyanli A, Cefle A, Sayarlioglu M, Inanc M, Aral O, Konice M, ‘‘A patient with classical polyarteritis nodosa evolving into end stage renal failure’’, Ren Fail, 25, 1037-41 (2003).
  • Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karaman O, Gul A, Ocal L, Aral O, Konice M, ‘‘Tuberculosis in Turkish Patients with Systemic Lupus Erythematosus: Increased Frequency of Extrapulmonary Localization’’ Lupus, 13, 274-78 (2004).
  • Sayarlioglu M, Kotan MC, Topcu N, Bayram I, Aslanturk H, Gul A, ‘‘Treatment of recurrent perforating intestinal ulcers with thalidomide in Behcet’s disease’’, Ann Pharmacother, 38, 808-11 (2004).
  • Sayarlioglu M, Topcu N, Harman M, Guntekin U, Erkoc R, ‘‘A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary arteries thrombosis’’, Rheumatol int,25, 65-8 (2005).
  • Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L, Aral O, Konice M, ‘‘Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases’’, Rheumatol Int, 25, 211-4 (2005).
  • Sayarlioglu H, Topal C, Sayarlioglu M, Dulger H, Dogan E, Erkoc R, ‘‘Effect of glucose concentration on inflammatory cytokines in continuous ambulatory peritoneal dialysis patients’’, Mediators inflamm, 13, 119-21 (2004).
  • Sayarlioglu M, Bayram I, Sayarlioglu H, Erkoc R, ‘‘Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Associated with Non-Hodgkin’s Lymphoma: A Case Report’’, Clin Rheum, 23, 188-9 (2004).
  • Sayarlioglu M, Cinal A, Topcu N, Demirok A, ‘‘Effect of infliximab on refractory uveitis in Behcet’s disease’’, Ann Pharmacother, 38, 901-2 (2004).
  • Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, Konica M, Gul A, ‘‘A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis’’, Rheumatol Int, 25, 442-46 (2004).
  • M. Sayarlioglu, A. Cefle, S. Kamali, A. Gul, M. Inanc, L. Ocal, O. Aral, M. Konice, “Characteristics of Patients with Late Onset Systemic Lupus Erythematosus in Turkey”, Int J Clin Pract, 59 183-7 (2005). (Listing criterion 2-late onset rheumatic diseases)
  • M. Sayarlioglu, A. Cefle, M. Inanc, S. Kamali, E. Dalkilic, A. Gul, L. Ocal, O. Aral, M. Konice, “Characteristics of Patients with Adult-Onset Familial Mediterranean Fever in Turkey: Analysis of 401 Cases”, Int J Clin Pract, 59, 202-5 (2005).
  • H. Sayarlioglu, R. Erkoc, E.Dogan, M.Sayarlioglu, C.Topal, “Mycophenolate Mofetil Use in Hepatitis B Associated Membranous and Membranoproliferative Glomerulonephritis Induces Viral Replication”, Ann Pharmacother, 39:573, 2004.
  • Sayarlioglu H, Dogan E, Erkoc R, Ozbek H, Sayarlioglu M, Sekeroglu R, Bozkurt H. The effect of colchicine on the peritoneal membrane. Ren Fail, 28:69-75, 2006.
  • Sayarlioglu H, Erkoc R, Etlik O, Sayarlioglu M, Dogan E, Esen R. Effect of CAPD on Hepatosteatosis and Lipid Profile, Nephrol Dial Transplant, 21:554, 2006.
  • Dogan E, Erkoc R, Demir C, Sayarlioglu H, Dilek I, Sayarlioglu M. Effect of hormone replacement therapy on CD4+ and CD8+ numbers, CD4+/CD8+ ratio, and immunoglobulin levels in hemodialysis patients. Ren Fail, 27:421-4, 2005
  • Sayarlioglu H, Erkoc R, Sayarlioglu M, Dogan E, Kara PS, Begenik H. Sheehan syndrome presented with acute renal failure associated with rhabdomyolysis and hyponatraemia. Nephrol Dial Transplant, 21:827-8, 2006.
  •  Sayarlioglu M, Topcu N, Harman M, Guntekin U, Erkoc R. A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis. Rheumatol Int, 25:65-8, 2005.
  • Sayarlioglu H, Erkoc R, Demir C, Dogan E, Sayarlioglu M, Oner AF, Dilek I. Nutritional status and immune functions in maintenance hemodialysis patients. Mediators Inflamm, 2006:20264, 2006.
  • Sayarlioglu H, Erkoc R, Sayarlioglu M, Dogan E, Soyoral Y. Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases. Rheumatol Int, 27:197-9, 2006.
  • Sayarlioglu H, Erkoc R, Tuncer M, Soyoral Y, Esen R, Gumrukcuoglu HA, Dogan E, Sayarlioglu M. Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study. Ren Fail, 29:143-6, 2007.
  • Pay S; Society for Research and Education in Rheumatology of Turkey. Risk of cancer in Turkish patients after treatment with TNF antagonists. Rheumatology (Oxford), 47:548-9, 2008.
  • Sayarlioglu M, Sayarlioglu H, Ozkaya M, Balakan O, Ucar MA. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still's disease: case report and review of the literature. Mod Rheumatol,18:403-6, 2008.
  • Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Gunduz M, Ispiroglu M, Tuncer C. Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol, 32:308-13, 2009.
  •  Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Altun B, Nacar AB, Gunduz M, Tuncer C. Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography, 26:549-57, 2009.
  •  Akcay A, Acar G, Sayarlioglu M, Sokmen A, Kaya H, Ispiroglu M, Koroglu S. QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol, 19:550-5, 2009.
  • Sayarlioglu M, Calka O, Cinal A, Sayarlioglu H, Akdeniz N, Topcu N, Durmus AC, Demirok A, Ilhan B, Gul A. Comparison of argon laser photocoagulation-induced cutaneous inflammation and skin pathergy test in Behçet's disease. Clin Rheumatol, 29:59-63, 2010.
  • Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, Aral O, Konice M. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int, Dec 11. 2009.
  • Acar G, Sayarlioğlu M, Akçay A, Sökmen A, Sökmen G, Yalçintaş S, Nacar AB, Gündüz M, Tuncer C. Evaluation of atrial electromechanical delay and left atrial mechanical functions in patients with rheumatoid arthritis. Turk Card. Assoc. Ars, 37:447-53, 2009.
  • Sayarlioglu M, Sahin M, Cetin GY, Avan R, Cerit M. Maternal exposure to leflunomide and methotrexate in a patient with adult-onset Still's disease. Rheumatology (Oxford), 49:1787-9, 2010.
  • Sayarlioglu M, Yuzbasioglu N, Inanc M, Kamali S, Cefle A, Karaman O, Onat AM, Avan R, Cetin GY, Gul A, Ocal L, Aral O. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int. 2010 Aug 15.

Professorship (Covered SCI):

  • Sayarlioglu M, Yuzbasioglu N, Inanc M, Kamali S, Cefle A, Karaman O, Onat AM, Avan R, Cetin GY, Gul A, Ocal L, Aral O. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int. 2010 Aug 15.
  • Pehlivan Y, Gogebakan B, Oztuzcu S, Ozgen M, Cetin GY, Bayraktar R, Cengiz B, Kisacik B, Koca SS, Donmez S, Sayarlioglu M, Demiryurek AT, Onat AM. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis. J Rheumatol 2012;39:106-11. doi: 10.3899/jrheum.110509.
  • Sayarlioğlu H, Gül M, Eren Dağli C, Doğan E, Sahin M, Uçar MA, Köksal N, Sayarlioğlu M, Tahta M. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients. Tuberk Toraks. 2011; 59:105-10.
  • Çetin GY, Sayarlıoğlu H, Erhan Ç, Kahraman H, Cıralık H, Sayarlıoğlu M. A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast. Eur J Rheumatol. 2014; 1:170-171. Epub 2014 Dec 1.
  • Direskeneli H, Akkoç N, Bes C, Cakir N, Cefle A, Cobankara V, Dalkilic E, Dinc A, Ertenli I, Gul A, Hamuryudan V, Inanc M, Kalyoncu U, Karaaslan Y, Kasifoglu T, Keser G, Keskin G, Kisacik B, Kiraz S, Masatlioglu S, Onat AM, Ozbek S, Ozturk MA, Pamuk ON, Pay S, Pirildar T, Sayarlioglu M, Senel S, Senturk T, Tasan D, Terzioglu E, Yazici A, Yucel E. Impact of rheumatoid arthritis in Turkey: a questionnaire study. Clin Exp Rheumatol. 2014;32:477-83.
  • Ozkan F, Cetin GY, Sayarlioglu M. Sonographic appearance of pseudopodagra in Behçet's disease. Rev Bras Reumatol. 2014;54:75-6.
  • Ozyurt K, Celik A, Sayarlıoglu M, Colgecen E, Incı R, Karakas T, Kelles M, Cetin GY. Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis. J Oral Pathol Med. 2014;43:691-5. doi: 10.1111/jop.12182.
  • Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A, Kasapcopur O, Kasifoglu T, Kisacik B, Ozdogan H, Tunca M, Acikel C, FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR) and Turkish FMF study group. FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis. 2014;73:897-901. doi: 10.1136/annrheumdis
  • Acar GR, Akkoyun M, Nacar AB, Dirnak I, Yıldırım Çetin G, Nur Yıldırım M, Zencir C, Karaman K, Cetin M, Sayarlıoğlu M. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turkish Card.Assoc. Ars. 2014;42:29-34. doi: 10.5543/tkda.2014.52959.
  • Kisacik B, Onat AM, Kasifoglu T, Pehlivan Y, Pamuk ON, Dalkilic E, Donmez S, Bilge SY, Yilmaz S, Erdem H, Mercan R, Ozturk MA, Bes C, Soy M, Erten S, Cobankara V, Senel S, Oner FA, Direskeneli H, Yilmaz S, Yazici A, Emmungil H, Aksu K, Kul S, Cetin GY, Sayarlioglu M. Diagnostic dilemma of paraneoplastic arthritis: case series. Int J Rheum Dis. 2014;17:640-5. doi: 10.1111/1756-185X.12277.
  • Yildirim Cetin G, Gul O, Kesici-Metin F, Gokalp İ, Sayarlıoglu M. Evaluation of the Mean Platelet Volume and Red Cell Distribution Width in FMF: Are They Related to Subclinical Inflammation or Not? Int J Chronic Dis. 2014; 2014:127426. doi: 10.1155/2014/127426.
  • Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford). 2014;53:741-5. doi: 10.1093
  • Ozkan F, Bakan B, Inci MF, Kocturk F, Cetin GY, Yuksel M, Sayarlioglu M. Assessment of enthesopathy in patients with fibromyalgia by using new sonographic enthesitis index.Rev Bras Reumatol. 2013; 53:335-40.
  • Yildirim Cetin G, Sayar H, Ozkan F, Kurtulus S, Kesici F, Sayarlioglu M. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature. Lupus. 2013; 22:839-46. doi: 10.1177/0961203313492242.
  • Pamuk ON, Kisacik B, Pamuk GE, Onat AM, Sayarlioglu M, Donmez S, Pehlivan Y, Keystone EC. Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study. Rheumatol Int. 2013;33:2631-5. doi: 10.1007/s00296-013-2792-2.
  • Harman E, Sayarlıoglu M, Harman M, Sayarlıoglu H. The evaluation of coagulation parameters and vessel involvement in Behcet' s disease. A clinical experience of Behcet' s disease: study of 152 cases. Acta Med Iran. 2013 May 7; 51:215-23.
  • Kisacik B, Dag MS, Pehlivan Y, Ugurlu K, Mercan OK, Aydinli M, Devay SD, Sayarlioglu M, Onat AM. Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis. Rheumatol Int. 2014;34:873-4. doi: 10.1007/s00296-013-2777-1.
  • Ozkan F, Cetin GY, Inci MF, Bakan B, Yuksel M, Ekerbicer HC, Sayarlioglu M. Increased enthesopathy in patients with familial Mediterranean fever: evaluation with a new sonographic enthesitis index. J Ultrasound Med. 2013;32:325-32.
  • Ozkan F, Cetin GY, Bakan B, Kalender AM, Yuksel M, Ekerbicer HC, Sayarlioglu M. Sonographic evaluation of subclinical entheseal involvement in patients with Behçet disease. AJR Am J Roentgenol. 2012 Dec;199(6): W723-9. doi: 10.2214/AJR.12.8576.
  • Onat AM, Pehlivan Y, Turkbeyler IH, Demir T, Kaplan DS, Ceribasi AO, Orkmez M, Tutar E, Taysi S, Sayarlioglu M, Kisacik B. Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension. Inflammation. 2013 Apr;36(2):405-12. doi: 10.1007/s10753-012-9559-x.
  • Gerdan V, Akar S, Solmaz D, Pehlivan Y, Onat AM, Kisacik B, Sayarlioglu M, Erhan C, Tezcan ME, Ozturk MA, Onen F, Akkoc N. Initial diagnosis of lumbar disc herniation is associated with a delay in diagnosis of ankylosing spondylitis. J Rheumatol. 2012; 39:1996-9. doi: 10.3899/jrheum.
  • Öztürk MA, Kaya A, Şenel S, Dönmez S, Balkarlı A, Çobankara V, Erhan Ç, Sayarlıoğlu M, Ugan Y, Tunç ŞE, Pehlivan Y, Kısacık B, Tufan A, Onat AM, Tezcan E, Yıldırım Çetin G, Pamuk ON. Demographic and clinical features of gout patients in Turkey: a multicenter study. Rheumatol Int. 2013;33:847-52. doi: 10.1007/s00296-012-2442-0.
  • Kisacik B, Kaya SU, Pehlivan Y, Tasliyurt T, Sayarlioglu M, Onat AM. Decreased vitamin D levels in patients with familial mediterranean fever. Rheumatol Int. 2013 May;33(5):1355-7.
  • Çetin G, Utku U, Atilla N, Gişi K, Sayarlioğlu M. Changes in Cerebral Blood Flow in Patients with Familial Mediterranean Fever. Noro Psikiyatr Ars. 2017; 54:105-107. doi: 10.5152/npa.2016.12396.
  • Öztürk MA, Mercan R, Gök K, Onat AM, Kısacık B, Kimyon G, Balkarlı A, Kaya A, Çobankara V, Balcı MA, Pamuk Ö, Yıldırım Çetin G, Sayarlıoğlu M, Şenel S, Tezcan ME, Küçük A, Üreten K, Şahin Ş, Tufan A. The management of gout in different clinical specialties in Turkey: a patient-based survey. Clin Rheumatol. 2016; 35:3019-3024.
  • Pamuk ÖN, Kalyoncu U, Aksu K, Omma A, Pehlivan Y, Çağatay Y, Küçükşahin O, Dönmez S, Çetin GY, Mercan R, Bayındır Ö, Çefle A, Yıldız F, Balkarlı A, Kılıç L, Çakır N, Kısacık B, Öksüz MF, Çobankara V, Onat AM, Sayarlıoğlu M, Öztürk MA, Pamuk GE, Akkoç N. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients. Rheumatol Int. 2016;36:945-53. doi: 10.1007/s00296-016-3500-9.
  • Kalyoncu U, Solmaz D, Emmungil H, Yazici A, Kasifoglu T, Kimyon G, Balkarli A, Bes C, Ozmen M, Alibaz-Oner F, Erten S, Cagatay Y, Cetin GY, Yilmaz S, Yildiz F, Pamuk ON, Kucuksahin O, Kilic L, Yazisiz V, Karadag O, Koca SS, Hayran M, Akar S, Aksu K, Akkoc N, Keser G, Gonullu E, Kisacik B, Onat AM, Soy M, Inanc N, Direskeneli H, Sayarlioglu M, Erken E, Turgay M, Cefle A, Ertenli I, Pay S. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort. J Autoimmun. 2016; 69:59-63. doi: 10.1016/j.jaut.2016.02.010.
  • Ozen G, Inanc N, Unal AU, Bas S, Kimyon G, Kisacik B, Onat AM, Murat S, Keskin H, Can M, Mengi A, Cakir N, Balkarli A, Cobankara V, Yilmaz N, Yazici A, Dogru A, Sahin M, Sahin A, Gok K, Senel S, Pamuk ON, Yilmaz S, Bayindir O, Aksu K, Cagatay Y, Akyol L, Sayarlioglu M, Yildirim-Cetin G, Yasar-Bilge S, Yagci I, Aydin SZ, Alibaz-Oner F, Atagunduz P, Direskeneli H. Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study. J Rheumatol. 2016; 43:893-900. doi: 10.3899/jrheum.151103.
  • Kisacik B, Pamuk ON, Onat AM, Erer SB, Hatemi G, Ozguler Y, Pehlivan Y, Kilic L, Ertenli I, Can M, Direskeneli H, Keser G, Oksel F, Dalkilic E, Yilmaz S, Pay S, Balkarli A, Cobankara V, Cetin GY, Sayarlioglu M, Cefle A, Yazici A, Avci AB, Terzioglu E, Ozbek S, Akar S, Gul A. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence. J Rheumatol. 2016; 43:524-9. doi: 10.3899/jrheum.150177.
  • Koca SS, Pehlivan Y, Kara M, Alibaz-Oner F, Oztuzcu S, Yilmaz N, Cetin GY, Kisacik B, Ozgen M, Pamuk ON, Direskeneli H, Sayarlioglu M, Onat AM. The IL-33 gene is related to increased susceptibility to systemic sclerosis. Rheumatol Int. 2016;36:579-84. doi: 10.1007/s00296-015-3417-8.
  • Pehlivan Y, Yolbas S, Cetin GY, Alibaz-Oner F, Cagatay Y, Yilmaz N, Oztuzcu S, Donmez S, Ozgen M, Koca SS, Pamuk ON, Sayarlıoglu M, Kisacik B, Direskeneli H, Demiryurek AT, Onat AM. Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis. Rheumatol Int. 2016;36:421-7. doi: 10.1007/s00296-015-3400-4.
  • Oztuzcu S, Onat AM, Pehlivan Y, Alibaz-Oner F, Donmez S, Cetin GY, Yolbas S, Bozgeyik I, Yilmaz N, Ozgen M, Cagatay Y, Kisacik B, Koca SS, Pamuk ON, Sayarlioglu M, Direskeneli H, Demiryurek aT. Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis. In Vivo. 2015; 29:763-70.
  • Yildirim Cetin G, Ganiyusufoglu E, Solmaz D, Cagatay Y, Yılmaz Oner S, Erer B, Sagliker HS, Avci AB, Akar S, Pamuk ON, Kılınc M, Kasifoglu T, Direskeneli H, Gul A, Sayarlioglu M. The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis. Amyloid. 2015; 22:207-8. doi: 10.3109/13506129.2015.1068751.
  • Yilmaz N, Emmungil H, Gucenmez S, Ozen G, Yildiz F, Balkarli A, Kimyon G, Coskun BN, Dogan I, Pamuk ON, Yasar S, Cetin GY, Yazici A, Ergulu Esmen S, Cagatay Y, Yilmaz S, Cefle A, Sayarlioglu M, Kasifoglu T, Karadag O, Pehlivan Y, Dalkilic E, Kisacik B, Cobankara V, Erken E, Direskeneli H, Aksu K, Yavuz S. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases. J Rheumatol. 2015 Sep;42(9):1661-6. doi: 10.3899/jrheum.150065.
  • Alibaz-Oner F, Karadeniz A, Ylmaz S, Balkarl A, Kimyon G, Yazc A, Çnar M, Ylmaz S, Yldz F, Bilge ŞY, Bilgin E, Coskun BN, Omma A, Çetin GY, Çağatay Y, Karaaslan Y, Sayarlioğlu M, Pehlivan Y, Kalyoncu U, Karadağ Ö, Kaşifoğlu T, Erken E, Pay S, Çefle A, Kisacik B, Onat AM, Çobankara V, Direskeneli H. Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore). 2015 Feb;94(6): e494. doi: 10.1097/MD.0000000000000494.
  • Cetin GY, Balkarli A, Öksüz AN, Kimyon G, Pehlivan Y, Orhan O, Kisacik B, Cobankara V, Sayarlioglu H, Onat AM, Sayarlioglu M. Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF]. Rev Bras Reumatol. 2014; 54:356-9. doi: 10.1016/j.rbr.2014.03.022.
  • Öztürk MA, Mercan R, Gök K, Onat AM, Kısacık B, Kimyon G, Balkarlı A, Kaya A, Çobankara V, Balcı MA, Pamuk Ö, Yıldırım Çetin G, Sayarlıoğlu M, Şenel S, Tezcan ME, Küçük A, Üreten K, Şahin Ş, Tufan A. The management of gout in different clinical specialties in Turkey: a patient-based survey. Clin Rheumatol. 2016 Dec;35(12):3019-3024.
  • Pamuk ÖN, Kalyoncu U, Aksu K, Omma A, Pehlivan Y, Çağatay Y, Küçükşahin O, Dönmez S, Çetin GY, Mercan R, Bayındır Ö, Çefle A, Yıldız F, Balkarlı A, Kılıç L, Çakır N, Kısacık B, Öksüz MF, Çobankara V, Onat AM, Sayarlıoğlu M, Öztürk MA, Pamuk GE, Akkoç N. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients. Rheumatol Int. 2016 Jul;36(7):945-53. doi: 10.1007/s00296-016-3500-
  • Çetin G, Utku U, Atilla N, Gişi K, Sayarlioğlu M. Changes in the Cerebral Blood Flow Velocity in Patients with Familial Mediterranean Fever. Noro Psikiyatr Ars. 2017 Jun;54(2):105-107. doi: 10.5152/npa.2016.12396. Epub 2016 Dec 8
  • Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erten A, Balkarli A, Kucuksahin O, Yilmaz Oner S, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Alibaz Oner F, Tezcan ME, Pamuk ON, Onen F.  A Nationwide Experience With The Off-label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. Arthritis Care Res (Hoboken). 2017 Oct 9. doi: 10.1002/acr.23446. [Epub ahead of print
  • Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Sayarlioglu M, Cınar M, Kasifoglu T. Comparison of early versus late onset familial Mediterranean fever. Int J Rheum Dis. 2018 Jan 5. doi: 10.1111/1756-185X.13259. [Epub ahead of print)
  • Articles Published in Other International Refereed Journals:
  • Sayarlıoğlu M. ‘‘Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and malignancy’’ Eur J Gen Med, 1: 3-5 (2004). (Derleme)
  • Dülger H, Alıcı S, Algün E, Etlik Ö, Sayarlıoğlu M, Doğan E, Sayarlıoğlu H, Şekeroğlu MR, “Antithyroid antibody levels in patients with breast cancer”, Eur J Gen Med, 1: 11-14, (2004).
  • M. Sayarlıoğlu, M. İzmirli, K. Uzun, S. Alıcı, R. Erkoç, “Rheumatoid Arthritis and Pulmonary Carcinoid Tumor: A Case Report”, Eur J Gen Med, 2: 35-8 (2005).
  • Akyol L, Aslan K, Özgen M, Sayarlioglu M.  A rare comorbidity: neurosarcoidosis and cutaneous sarcoidosis. BMJ Case Rep. 2015 Nov 17;2015. pii: bcr2015211439. doi: 10.1136/bcr-2015-211439
  • Akyol L, Aslan K, Özgen M, Sayarlioglu M. Bilateral sacroiliitis and uveitis comorbidity: brucellosis? Ankylosing spondylitis? BMJ Case Rep. 2015;2015. pii: bcr2015211461. doi: 10.1136/bcr-2015-211461.
  • Akyol L, Önem S, Özgen M, Sayarlıoğlu M. Sjögren's syndrome after silicone breast implantation. Eur J Rheumatol. 2015; 2:165-166.
  • Işıklı G, Akyol L, Uçak SS, Aslan K, Özgen M, Sayarlıoğlu M. Heterotopic ossification (myositis ossificans progressiva): A condition interfering with rheumatic disease. Eur J Rheumatol. 2017; 4:79-80. doi: 10.5152/eurjrheum.2016.15061.
  • Akyol L, Önem S, Özgen M, Sayarlıoğlu M. Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis. Eur J Rheumatol. 2016; 3:36-37.
  • Akyol L, Günbey E, Karlı R, Önem S, Özgen M, Sayarlıoğlu M. Evaluation of olfactory function in Behçet's disease. Eur J Rheumatol. 2016; 3:153-156. doi: 10.5152/eurjrheum.2016.017.
  • Işıklı G, Akyol L, Uçak SS, Aslan K, Özgen M, Sayarlıoğlu M. Heterotopic ossification (myositis ossificans progressiva): A condition interfering with rheumatic disease. Eur J Rheumatol. 2017 Mar;4(1):79-80. doi: 10.5152/eurjrheum.2016.15061. 
  • Dr. Zeliha Yarar (Master's thesis supervised): Evaluation of clinical, laboratory and treatment characteristics of late-onset ankylosing spondylitis patients (2017)
  • M. Sayarlioglu, A. Cefle, S. Kamali, A. Gul, M. Inanc, L. Ocal, O. Aral, M. Konice, “Characteristics of Patients with Late Onset Systemic Lupus Erythematosus in Turkey Int, Int J Clin Pract, 59 183-7 (2005).
  • M. Sayarlioglu, A. Cefle, M. Inanc, S. Kamali, E. Dalkilic, A. Gul, L. Ocal, O. Aral, M. Konice, “Characteristics of Adult-Onset Familial Mediterranean Fever in Turkey: Analysis of 401 Cases Int, Int J Clin Pract, 59, 202-5 (2005).
  • Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Unwritten V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Early E, Sayarlioglu M, Cınar M, Kasifoglu T. Comparison of early versus onset familial Mediterranean fever. Int J Rheum Dis. 2018 Jan 5. doi: 10.1111 / 1756-185X.13259. [Epub ahead of print]

Behcet 's disease:

  • Rheumatology specialty thesis (Mehmet Sayarlıoğlu): Determination of minimal dose of erythema producing ultraviolet B in Behçet's disease and its comparison with skin pathergy test
  • Supervised master thesis (Dr Ece Harman): Evaluation of coagulation parameters in Behçet's disease patients, 2005
  • Sayarlioglu M, Calka O, Cinal A, Sayarlioglu H, Akdeniz N, Topcu N, Durmus AC, Demirok A, Ilhan B, Gul A. Comparison of argon laser photocoagulation-induced cutaneous inflammation and skin pathergy test in Behcet's disease. Clin Rheumatol., 29: 59-63, 2010.
  • Aa68, Aa49, Ab8, and other studies

Reports Presented at International Scientific Meetings and Published in The Proceedings:

  • Sayarlıoğlu M, Sayarlıoğlu H, Bayraktaroğlu T, Trablus S, Kurtulmuş N, Erhan N, ‘‘Relationship of glisemia regulation with serum magnesium and lipid values in type II diabetic patients’’, Black Sea Diab Meeting, İstanbul, B-18, (1997).
  • Sekeroglu M.R, Dulger H, Tarakcioglu M, Algun E, Aksoy H, Sayarlioglu M, Erkoc R, Dilek I, Noyan T, ‘‘Thyroglobulin levels of endemic goiter patients living in Yumaklı village of Van, Turkey’’, 17th International and 13th European Congress of Clinical Chemistry and Laboratory Medicine, Italy, 194, M308, (1999).
  • Erkoc R, Aksoy H, Ilhan M, Dulger H, Sekeroglu R, Tarakcioglu M, Alici S, Sayarlioglu M, Dilek I, ‘‘Hyperuricemia and various correlated parameters in people of Van city’’, 17th International and 13th European Congress of Clinical Chemistry and Laboratory Medicine, Italy, 332, W039, (1999).
  • Erkoc R, Aksoy H, Alici S, Ilhan M, Sayarlioglu M, Dulger H, Uygan I, Avcı E, ‘‘Crossectional population, survey for creatinine values and some related parameters in people of Van city, Turkey’’, European Dialysis and Transplant Association Annual Congress, Madrid, Nephrol Dial Transplant, Vol. 14, A119, (1999).
  • Cefle A, Sayarlioglu M, Inanc M, Dalkilic E, Kamali S, Gul A, Ocal L, Aral O, Konice M, ‘‘Different forms of vasculitis associated with familial Mediterranean fever’’, Familial Mediterranean Fever II. International Conference, Antalya, 90, D21(P), (2000).
  • Sayarlioglu M, Cefle A, Inanc M, Dalkilic E, Gul A, Ocal L, Aral O, Konice M, ‘‘The prevalence and clinical characteristics of late-onset familial Mediterranean fever’’, Familial Mediterranean Fever II. International Conference, Antalya, 92, D30(P), (2000).
  • Aksoy H, Ozbek H, Turkdogan K, Algun E, Dilek I, Tuncer I, Ugras S, Erkoc R, Sayarlioglu M, Alici S, Ilhan M, Sahin I, Memik F, ‘‘Is hereby cheese ulcerogenic’’, 11th World Congress of the International Association of Surgeons and Gastroenterologists, Hepato-Gastroenterology, Grecia, Vol. 48, Supp. 1, P99, (2001).
  • Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, Aral O, Konice M, ‘‘Pulmonary hypertension in patients with systemic lupus erythematosus: Relationship with antiphospholipid antibodies and severe disease outcome’’ The Sixth International Lupus Conference, Barcelona, Lupus, Vol. 10, Supp. 1, 64, P173, (2001).
  • Cefle A, Sayarlioglu M, Kamali S, Inanc M, Gul A, Ocal L, Aral O, Konice M, ‘‘Comparison of the SLICC/ACR damage scores in male and female patients with systemic lupus erythematosus’’, The Sixth International Lupus Conference, Barcelona, Lupus, Vol. 10, Supp. 1, 106, P302, (2001).
  • Kamali S, Gul A, Inanc M, Cefle A, Sayarlioglu M, Aral O, Konice M, ‘‘Monthly intravenous immunoglobuline therapy in patients with systemic lupus erythematosus’’ The Sixth International Lupus Conference, Barcelona, Lupus, Vol. 10, Supp. 1, 100, P281, (2001).
  • Sayarlioglu M, Cefle A, Kamali S, Gul A, Inanc M, Ocal L, Aral O, Konice M, ‘‘Characteristics of patients with late onset systemic lupus erythematosus’’, The Sixth International Lupus Conference, Barcelona, Lupus, Vol. 10, Supp. 1, 78, P230, (2001).
  • Inanc M, Oncu S, Gul A, Kamali S, Cefle A, Sayarlioglu M, Ocal L, Aral O, Konice M, ‘‘Comparison of organ damage in systemic lupus erythematosus patients with and without antiphospholipid syndrome’’, Annual European Congress of Rheumatology, Prague, Ann Rheum Dis, Vol. 60, Supp. 1, 187, FRI0143, (2001).
  • Kamali S, Gul A, Inanc M, Cefle A, Sayarlioglu M, Aral O, Konice M, ‘‘Experience with intravenous immunoglobulin therapy in twenty patients with different autoimmune rheumatic diseases’’, Annual European Congress of Rheumatology (EULAR 2001), Prague, Ann Rheum Dis, Vol. 60, Supp. 1, 341, AB0212, (2001).
  • Sayarlioglu M, Inanc M, Kamali S, Karaman O, Cefle A, Gul A, Ocal L, Aral O, Konice M, ‘‘Tuberculosis in patients with systemic lupus erythematosus; Increased frequency of extrapulmonary localization’’, Annual European Congress of Rheumatology (EULAR 2001), Prague, Ann Rheum Dis, Vol. 60, Supp. 1, 188, FRI0144, (2001).
  • Sayarlioglu M, Kamali S, Inanc M, Ocal L, Aral O, Konice M, Gul A ‘‘UVB Induced erythema in Behcet’s disease’’ 10th International Conference on Behçet’s Disease, Berlin, 60, Abstract:016, (2002).
  • Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, Konice M, Gul A, ‘‘A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis’’, Annual European Congres of Rheumatology (EULAR 2002), Stockholm, Ann Rheum Dis, Vol. 61, Supp. 1, 248, P0322, (2002).
  • Sayarlioglu M, Calka O, Cinal A, Sayarlioglu H, Akdeniz N, Topcu N, Durmus A, Demirok A, Ilhan B, Gul A, ‘‘Comparison of Argon Laser Photocoagulation Induced Cutaneus Inflammation and Skin Pathergy Test in Behcet’s Disease’’, Annual European Congress of Rheumatology (EULAR 2003), Lisbon, Ann Rheum Dis, Vol. 62, Supp. 1, 217, FRI0061, (2003).
  • M. Ozkaya, M. Sayarlioglu, O. Balakan, T. Sonmez, K. Gisi, E. Aydinlik, R. Avan, G. Yildirim Cetin, H. Sayarlioglu. Changes in plasma levels of pre-B cell colony-enhancing factor/visfatin and metabolic parameters in patients with rheumatoid arthritis. Annual European Congress of Rheumatology (EULAR), Paris, AB0208, (2008).
  • H. Sayarlioglu, M. Sayarlioglu, S. Cekici, E. Dogan, P. Kara, R. Erkoc. Evaluation of renal functions in patients with Behcet’s disease. Ann Rheum Dis 2008;67(Suppl II):643 [Annual European Congress of Rheumatology (EULAR 2008), Paris, AB0955.
  • E. Harman, M. Sayarlioglu, C. Demir, H. Sayarlioglu, O. Calka, N. Akdeniz, P. Kara, M. Harman. Coagulation parameters and thrombosis in Behcet’s disease. Annual European Congress of Rheumatology (EULAR 2008) (AB0956), Paris, Ann Rheum Dis 2008;67(Suppl II):643
  • Akar S, Gerdan V, Solmaz D, Sayarlioglu M, Ozturk MA and fri. An initial diagnosis of lumbar disc hernation is associated with a late refferral to the rheumatologist and a delay in the dagnosis of ankylosing spondylitis. American College of Rheumatology, Atlanta/Georgia, November 6-11, Abstract no:1921, 2010.
  • Cefle A, Sayarlioglu M, Kamali S, Yazici A, Inanc M, Aral O. A comparison of clinical and laboratory findings of 55 Turkish male SLE patients with female patients. Annual European Congress of Rheumatology (EULAR 2010), Roma, AB0416
  • B23- M. Sayarlioglu, G. Yildirim Cetin, Y. Pehlivan, Relationship between positivity of skin pathergy reaction and demographic, clinical, laboratory, and management characteristics of patients with Behcet’s disease (EULAR 2011). Londom, England, AB 0977.
  • Avan R, Cetin GY, Cerit M,. Risk factors for avascular necrosis in patients with SLE and other rheumatic disease (EULAR 2011). London, England. AB 0825.
  • Cetin GY, Sayarlioglu H, Orhan O, et al. Evaluation of the factors affecting colchicum resistance, treatment adherence and accuracy of diagnosis in colchicum resistant FMF patients. EULAR 2012, AB1223.
  • Kisacik B, Onat AM, Kasifoglu T, Paraneoplastic arthritis: A multicentered experience. EULAR 2012. THU0361.
  • Yilmaz N, Emmungil H, ozen G, Cyclophosphamide induced bladder toxicity and protective effect of 2-Mercaptoethane sulfonate (MESNA) in systemic autoimmune disorders. EULAR 2013. Sat0538. Madrid, Spain.
  • Kalyoncu U, Solmaz D, Emmungil H, Delay od diagnosis in Still’s disease is associated with a chronic/relapsing pattern: national, multicenter study of 356 patients. (EULAR 2013) THU0491. Madrid, Spain.
  • Pehlivan Y, Oztuzcu S, Donmez S,. Investigating the association between Rho-kinase 1 (ROCK1) gene polimorphism and systemic sclerosis. EULAR 2013. SAT0222. Madrid, Spain.
  • Cetin GY, Gul O, Kesici-Metin F, Gokalp I, Sayarlioglu M. MPV and RDW: Subclinical inflammation markers in attack-free FMF patients. EULAR 2013. THU0458. Madrid, Spain.
  • Koca SS, Pehlivan Y, Kara M,. The RS11792633-T allele of IL33 gene is associated with systemic sclerosis. EULAR 2013. AB0152. Madrid Spain.
  • Cetin GY, Ganiyusufolu E, Solmaz D, Association Between the Presence Of Amyloidosis In Patients With Ankylosing Spondylitis and Polymorphisms In Type 1/Type 2 Serum Amyloid A Protein Genes, Mediterranean Fever Genes. 2013 ACR Annual Meeting. AN:523
  • Kasifoglu T, Yasar S, sari I, Amyloidosis and Its Related Factors In Patients With Familial Mediterranean Fever: A Nationwide Multicenter Study. 2013 ACR Annual Meeting. AN:2749
  • Solmaz D, Akar S, Kisacik B, Comparison of characteristics of ankylosing spondilitis in association with FMF with those of typical ankylosing spondylitis. (EULAR 2014) THU0072. Paris France.
  • Kisacik B, pamuk ON, Onat AM, Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases. 2014 ACR Annual Meeting. AN: 2157
  • Cetin GY, Utku U, Atilla N, Gişi K, Sayarlioglu M. Changes in Cerebral Blood Flow Velocity in Patients with Familial Mediterranean Fever. 2014 ACR Annual Meeting. AN:2270
  • Pamuk ON, kalyoncu U, Aksu K, Are Biologic Agents Effective on the Treatment of Secondary Amyloidosis: A Multicenter Report on Turkish Rheumatoid Arthritis and Ankylosing Spondylitis Patients. 2014 ACR Annual Meeting. AN: 2523
  • Solmaz D, Akar S, Kisacik B,. Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis. 2014 ACR Annual Meeting. AN: 2616
  • Alibaz Oner F, Karadeniz A, Yilmaz S,. Effects of Anticoagulant Treatment on the Incidence of New Vascular Events in Patients with Behcet’s Disease with Vascular Involvement. 2014 ACR Annual Meeting. AN: 2750
  • Alibaz Oner F, Karadeniz S, Yilmaz S, Effects of anticoagulant treatment on the incidence of new vascular events in patiemnts with Behcet’s disease with vascular involvement. EULAR 2014. OP0234.
  • Akyol L, Aslam K, Ozgen M, sayarlioglu M. Behcet’s disease complicated with cerebral venous sinüs thrombosis: A report of nine cases. EULAR 2015. THU0559. Roma/Italy.
  • uygar U, Yildirim cetin G, Atilla N, Gişi M, Sayarlioglu M. Changes in cerebral blood flow in patients with rheumatoid artritis. EULAR 2015. AB0349. Roma/Italy.
  • Akyol L, Toz B, Bayindir O, Budd-Chiari Syndrome in Behçet’s Disease: a Retrospective Multicenter Study. ACR Annual Meeting 2015. AN: 3052.
  • Kalyoncu U, Solmaz D, Emmungil H. Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult-Onset Still’s Disease.  ACR Annual Meeting 2015. AN:269
  • Solmaz D, cetin P, pamuk ON,. The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household.  ACR Annual Meeting 2015. AN: 690.
  • Ozgen M , Akyol B, sahin M, Sayarlioglu M. comparison of tuberculin skin test and T-spot.TB test in patients with receiving corticosteroid or immunsupressive treatments. EULAR 2015. Roma/Italy. AB0036.
  • Aydin SZ, Yilmazer B, Bayindir O. Hydroxychloraquine does not increase psoriasis in psoriatic arthritis: Time on drug analysis based on real life data. EULAR 2015. Roma /Italy. AB0827.
  • Ozyurk MA, mercan R, Gok K,. Management of gout in different clinical specialities in Turkey. EULAR 2015. Roma/Italy. AB0914.
  • Kalyoncu U, Yilmazer B, bayindir O,. Performance of different inflammatory back pain criteria in psoriatic arthritis with chronic low back pain. EULAR 2015. SAT0583
  • Solmaz D, cetin P, pamuk ON, l. The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household.  EULAR 2015. Roma/Italy. SAT0241.
  • Ozen G, Bas S, unal AU,. Validation of new 2012 EULAR/ACR clinical classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a prospective multi-center study. EULAR 2015. Roma/Italy. FRI0265.
  • Eren fidanci B, Yesilkaya S, Acikel C,. Validity and reliability of medication adherence scale in FMF (Adult version). EULAR 2015. Roma/Italy. AB1118
  • Emmungil H, Erden A, kucuksahin O,. The clinical and demographic features of relapsing polychondritis: A nationwide study. EULAR 2016. FRI0373. London/United Kingdom
  • Kalyoncu U, Bayindir O, Oksuz MF,. Dapsa-28 may be used instead of Dapsa-66/68 in psoriatic arthritis. ACR Annual Meeting 2016. AN: 2747
  • Akar S, Cetin P, Kalyoncu U,. A Nationwide Experience with the Off Label Use of Interleukin 1 Targeting Treatment in Familial Mediterranean Fever Patients. ACR Annual Meeting 2016. AN: 942.
  • Alibaz-Oner F, Unal AU, Onat AM,. Clinical Features of  Takayasu’s Arteritis from an Inception Cohort: Early Disease Is Characterized By ‘systemic Inflammation’. ACR Annual Meeting 2016. AN: 901.
  • Karadag O, Dalkilic E, Onat AM,. Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis. ACR Annual Meeting 2016. AN: 90.
  • Aydin SZ, bayindir O, Oksuz MF,. Psoriatic arthritis registry of Turkey (PSART): Results of multicenter registry on 1081 patients. EULAR 2016. London/UK. AB0747.
  • Aydin SZ, Bayindir O, Oksuz MF, l. Comorbidities in psoriatic arthritis: patient education counts. EULAR 2016. London /UK. FRI0476.
  • Akyol L, Toz B, Bayindir O,. Budd-Chiari syndrome in Behcet's disease: A retrospective multicenter study.  EULAR 2017. THU0329. Madrid/Spain.

Articles Published in National Refereed Journals:

  • Dilek I, Öner A.F, Mete R, Erkoç R, Türkdoğan K, Topal C, Durmuş A, Sayarlıoğlu M, Aksoy H, In city Van of blood groups in Turkey and other comparison with some countries, '' Van Journal of Medicine, 5, 236-8 (1998).
  • . Sayarlıoğlu M, Demirsoy H, Sayarlıoğlu H, Öztürk L, 'Type 2 (NIDDM) diabetes mellitus' in serum magnesium levels and the relationship of glycemic regulation', Van Medical Journal, 5, 141-3 (1998).
  • Dilek İ, Mete R, Akdeniz H, Bozkurt H, Erkoç R, Sayarlıoğlu M, Topal C, Demiröz P, Aksoy H, Initial and empirical antibiotic therapy in neutropenic fever, Van Journal of Medicine, 5, 210-13 (1998)
  • Sayarlıoğlu M, Eryonucu B, Sayarlıoğlu H, “Hypertension and left ventricular hypertrophy ’’, Van Journal of Medicine, 5, 264-7 (1998). (Compilation).
  • Sayarlıoğlu M, Bayraktaroğlu T, Aras Ş, Trablus S, Sayarlıoğlu H, Bahtiyar İ, ‘‘hypertensive and non-hypertensive patients with type II Diabetes Mellitus is intraerythrocytary magnesium level, Turkey Medical Journal, 6, 24-28 (1999).
  • Eryonucu B, Sayarlıoğlu M, Bilge M, Güler N, Erkoç R, Dilek İ “Evaluation of the knowledge level and compliance of the hypertensive patients with hypertension in Van province and region, Van Journal of Medicine, 6, 11-14 (1999).
  • Dilek İ, Gul A, Ayakta H, Demirtaş İ, Mete R, Şahin HG, Sayarlıoğlu M, Aksoy H, ‘‘May floating thumb malformation be related to use of chemotherapeutic agents in pregnancy’’, Turk J Haematol, 16, 29-32 (1999).
  • Eryonucu B, Sayarlıoğlu M, Bilge M, Güler N, Erkoç R, Dilek İ, A preliminary study of the clinical features of patients with essential hypertension ', Turkey Medical Journal, 7, 32-34 (2000).
  • Erkoc R, Aksoy H, Alici S, İlhan M, Sayarlioglu M, Dilek İ, Uygan İ, Topal C, Meral C, ‘‘Hypertension prevalence in Van, Turkey-1997’’, Eastern Journal of Medicine, 6, 22-25 (2001).
  • Uzun K, Sayarlıoğlu M, Zehir İ, Topal C, Durmuş A, Antiphospholipid syndrome: Two cases with pulmonary complications Sol Sol Solunum, 4, 251-8 (2002).
  • Kamalı S, Çefle A, Sayarlıoğlu M, Dalkılıç E, Gul A, İnanç M, Öcal L, Aral O, Koniçe M, ‘‘Urticaria as the presenting manifestation of Churg Strauss syndrome’’, Medical Bullettin of İstanbul Medical Faculty, 35, 48-51 (2002).
  • Dalkılıç E, Çefle A, Kamalı S, Sayarlıoğlu M, Gül A, İnanç M, Öcal L, Aral O, Koniçe M, ‘‘Scleromyxedema: a rare disease with skin manifestations and systemic involvement- alveolitis and portal hypertension – report of two cases’’, Medical Bullettin of İstanbul Medical Faculty, 36, 28-32 (2003).
  • Sayarlıoğlu M, Topçu N, Systemic lupus erythematosus that begins at an advanced age, Van Journal of Medicine, 10, 83-87 (2003). (Compilation)
  • Kamalı S, Kasapoğlu E, Çefle A, Sayarlıoğlu M, Öcal L, Gül A, İnanç M, Aral O, Koniçe M, Clinical and laboratory features of 35 patients with primary Sjögren's syndrome: Istanbul Medical Faculty rheumatology experience ’’, Istanbul Medical Faculty Journal (2004).
  • M. Sayarlıoğlu. Pharmacological treatment of fibromyalgia. Turkey J Immunol Clinical Rheumatol-Special Topics 2: 51-58, 2009.
  • M. Sayarlıoğlu. Treatment of colchicine resistant familial Mediterranean fever and its complications. RAED journal 1; 20-25, 2010.
  • M. Sayarlıoğlu. The safety of osteoporosis drugs. Rheumatology 2010, 13-17 October Antalya, Speech texts: page 125
  • Papers Presented in National Scientific Meetings and Published in Proceedings:
  • Bayraktaroğlu T, Trablus S, Sayarlıoğlu M, Güney M, Yeşilkaya H, Davutoğlu M, Erhan N, Investigation of precipitating factors in cases with diabetic ketoacidosis between 1995-1997 34. 34., 34th National Diabetes Congress and 3rd International Obesity Symposium, 120, P50, Ankara, (1998).
  • Trablus S, Bayraktaroğlu T, Sayarlıoğlu M, Kurtulmuş N, Irmak G, Erdoğmuş M, Erhan N, Büyükdevrim A.S A case of newly diagnosed type II diabetes mellitus hospitalized with hyperosmolar nonketotic coma 34. 34., 34th National Diabetes Congress and 3rd International Obesity Symposium, 132, P62, Ankara, (1998).
  • Davutoğlu M, Trablus S, Davutoğlu C, Bayraktaroğlu T, Yeşilkaya H, Gültepe İ, Erdoğmuş M, Sayarlıoğlu M, Erhan N, Büyükdevrim S, Beler B, The prevalence of nephropathy in diabetes mellitus XX ’, XXI. National Endocrinology and Metabolism Diseases Congress, 188, P60, Istanbul, (1998).
  • Göktekin Ö, Kurt T, Bayraktaroğlu T, Sayarlıoğlu M, Erhan N,” Prevalence of early repolarization in patients admitted to emergency department” XIV. National Cardiology Congress, P305, Antalya, (1998).
  • . Dilek İ, Türkdoğan K, Erkoç R, Topal C, Sayarlıoğlu M, Mete R, Durmuş A, Uygan İ, Meral C, Aksoy H,” The effect of high dose methylprednisolone treatment on SGOT, SGPT, GGT, Alkaline Phosphatase, LDH and Albumin X ’, XIV. National Gastroenterology Congress, Turk J Gastroenterol, V. 9, Supp. 1, P371, Istanbul, (1998).
  • Dilek İ, Erkoç R, Sayarlıoğlu M, Alıcı S, İlhan M, Türkdoğan K, Topal C, Durmuş A, Aksoy H, “Ferritin levels in healthy individuals living in Van city center and rural areas XX ’, XXVI. National Hematology Congress, 159, P90, Ankara, (1998).
  • Dilek İ, Erkoç R, Sayarlıoğlu M, İlhan M, Alıcı S, Türkdoğan K, Meral C, Aksoy H, Hematological values in adults in central and rural areas of Van Province, XXVI. National Hematology Congress, 158, P89, Ankara, (1998).
  • Aksoy H, Erkoç R, Sayarlıoğlu M, Dilek İ, İlhan M, Alıcı S, Topal C, Uygan İ, “Goitre screening study in and around Van province and thyroid functions in individuals over 60 years old XX ’, XXI. National Endocrinology and Metabolism Diseases Congress, 86, S13, Istanbul, (1998).
  • Eryonucu B, Sayarlıoğlu M, Bilge M, Güler N, Erkoç R, Dilek İ, Evaluation of the knowledge level of hypertensive patients in Eastern Anatolia on hypertension XXX XXX, XXXIV. National Turkish Medical Congress, Istanbul, (1998).
  • . Eryonucu B, Sayarlıoğlu M, Güler N, Erkoç R, Bilge M, Üstün Y, Ayakta H, “Clinical features of hypertensive patients in Eastern Anatolia area ’, XXXIV. National Turkish Medical Congress, Istanbul, (1998).
  • Eryonucu B, Sayarlıoğlu M, Erkoç R, Bilge M, Güler N, Dilek İ, Evaluation of treatment compliance of hypertensive patients in Eastern Anatolia XXX ’, XXXIV. National Turkish Medical Congress, 28, Istanbul, (1998).
  • Aksoy H, Alıcı S, Algün E, Erkoç R, İlhan M, Sayarlıoğlu M, Ayakta H, Uygan İ, Topal C, Dilek İ, ‘‘The prevalence of obesity among adults in Van province is V ’, XXXV. National Diabetes Congress and IV. International Symposium on Obesity, 104, PS-2/6, Istanbul, (1999).
  • Dilek İ, Mete R, Akdeniz H, Bozkurt H, Erkoç R, Sayarlıoğlu M, Topal C, Demiröz P, Aksoy H,” Preliminary results of initial empirical antibiotic therapy in neutropenic fever ’3., 3rd Febrile Neutropenia Symposium, 115, P35, Antalya, (1999).
  • Erkoç R, Aksoy H, Alıcı S, İlhan M, Sayarlıoğlu M, Dilek İ, Uygan İ, Topal C, Meral C, ‘‘Prevalence of hypertension in Van Province I., I. National Hypertension and Renal Diseases Congress, 75, P16, Antalya, (1999).
  • Algün E, Aksoy H, Erkoç R, Sayarlıoğlu M, Uygan İ, Türkdoğan M.K, ‘‘Hepatitis C virus infection in patients with diabetes XXX ’, XXXV. National Diabetes Congress, 109, PS-3/14, Istanbul, (1999).
  • Çalka Ö, Metin A, Sayarlıoğlu M, Cesur R, ‘‘Profile of Behçet's disease in Van and surroundings ’, VII. National Behçet's Disease Congress, 10, S10, Istanbul, (1999).
  •  Sayarlıoğlu M, Aydın A, Kamalı S, Çefle A, Aral O, Koniçe M, ‘‘A case report: Arthropathy due to ochronosis”, National Rheumatology Congress, 40, P14, Antalya, (2000).
  • Sayarlıoğlu M, Çefle A, İnanç M, Dalkılıç E, Gül A, Öcal L, Aral O, Koniçe M,” 'The prevalence and clinical characteristics of late-onset familial Mediterranean fever Ulusal Ulusal, National Congress of Rheumatology, 72, P78, Antalya, (2000).
  • Çefle A, Sayarlıoğlu M, İnanç M, Dalkılıç E, Kamalı S, Gül A, Öcal L, Aral O, Koniçe M, Familial Mediterranean fever and vasculitis Ulusal Ulusal, National Congress of Rheumatology, 73, P79, Antalya, (2000).
  • Çefle A, Sayarlıoğlu M, Kamalı S, Gül A, İnanç M, Öcal L, Aral O, Koniçe M,” Comparison of clinical and laboratory findings of male patients with systemic lupus erythematosus to female patients Ulusal Ulusal, National Rheumatology Congress, 47, P27, Antalya, (2000).
  • Sayarlioglu M, Cefle A, Kamali K, Gul A, Inanc M, Ocal L, Aral O, Konica M, '' Examination of clinical, laboratory and treatment features of systemic lupus erythematosus in late age '' National Rheumatology Congress, 47, P28, Antalya, (2000).
  • Öncü Ş, İnanç M, Kamalı S, Çefle A, Sayarlıoğlu M, Gül A, Öcal L, Aral O, Koniçe M, ‘‘Evaluation of organ damage index in patients with systemic lupus erythematosus, National Rheumatology Congress, 23, S12, Antalya, (2000).
  • Kamalı S, Gül A, İnanç M, Çefle A, Sayarlıoğlu M, Aral O, Koniçe M, ‘‘Istanbul Faculty od Medicine, rheumatology in the field of intravenous immunoglobulin therapy experience ’’, National Rheumatology Congress, 52, P38, Antalya, (2000).
  • Çefle A, İnanç M, Sayarlıoğlu M, Kamalı S, Gül A, Öcal L, Aral O, Koniçe M, ‘‘Systemic lupus erythematosus and pulmonary hypertension Ulusal, National Congress of Rheumatology, 23, S11, Antalya, (2000).
  • Uzun K, Sayarlıoğlu M, Zehir İ, Topal C, Durmuş A, ‘‘Antiphospholipid syndrome (Report of two cases with lung complications) Thoracic Society 4th annual congress, 22, TP-81, Izmir, (2001).
  • Sayarlıoğlu M, Ozen S, Sayarlıoğlu H, Demir C, Gerçik F, ‘‘A case of familial Mediterranean fever developing myopathy after the use of standard dose colchicine, National Rheumatology Congress, 41, P97, Adana, (2002).
  •  Sayarlıoğlu M, Harman M, Aslan H, Etlik O, Topcu N, Çekici S, ‘‘Behçet's case with mediastinal fibrosis and superior thrombosis of the vena cava, National Rheumatology Congress, 36, P77, Adana, (2002).
  • Sayarlıoğlu M, Kamalı S, İnanç M, Ocal L, Aral O, Koniçe M, Gül A, ‘‘Determination of minimal dose of erythema producing ultraviolet B in Behcet 's disease and comparison of this with skin pathergy test. National Rheumatology Congress, 12, SB21, Adana, (2002).
  • Çefle A, Kamalı S, Sayarlıoğlu M, İnanç M, Öcal L, Aral O, Koniçe M, Gül A, ‘‘Comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis, National Congress of Rheumatology, 41, P100, Adana, (2002).
  • Alıcı S, Sayarlıoğlu M, Topçu N, Dilek İ,” Rheumatoid arthritis-malignancy relationship: Two case reports, XV. National Cancer Congress, 54, P097, Antalya, (2003).
  • Sayarlıoğlu H, Erkoç R, Topal C, Dülger H, Sayarlıoğlu M, ‘‘Acute effect of glucose concentration on inflammatory cytokines in patients undergoing continuous ambulatory peritoneal dialysis ’V. National Congress of Hypertension and Renal Diseases, 91, P051, Antalya, (2003).
  •  Beğenik H, Sayarlıoğlu M, “General Characteristics of Systemic Sclerosis Cases in, Van and Around Van, National Rheumatology Congress, (PS-045), 31 October-3 November 2004, Antalya.
  • Sayarlıoğlu M, Çalka O, Çınal A, Sayarlioglu H, Akdeniz N, Topcu N, Durmuş A, Demirok A, Ilhan B, Gul A, “Comparison of Skin Inflammation Induced by Argon Laser Photocoagulation in Behcet's Disease with Skin Pathergy Test Ulusal, National Rheumatology Congress, (PS-070), 31 October-3 November 2004, Antalya.
  • Sayarlıoğlu M, Çekici S, Beğenik H, “Evaluation of Demographic, Clinical and Treatment Characteristics of Patients with Rheumatoid Arthritis in and Around Van, National Congress of Rheumatology, (PS-046), 31 October-3 November 2004, Antalya.
  • Sayarlıoğlu M, Sayarlıoğlu H, Doğan E, Beğenik H, Reha Erkoç, “Van İli ve Çevresindeki Sistemik Lupus Eritematozus Hastalarının Demografik, Klinik, Laboratuar ve Tedavi Özelliklerinin Değerlendirilmesi”, Ulusal Romatoloji Kongresi, (PS-038), 31 Ekim-3 Kasım 2004, Antalya.
  • Sayarlıoğlu M, Harman E, Çınal A, Demirok A, “Evaluation of Demographic, Clinical and Treatment Characteristics of Behcet's Patients in and Around Van, National Rheumatology Congress, (PS-085), 31 October-3 November 2004, Antalya.
  • Sayarlıoğlu M, Sayarlıoğlu H, Doğan E, Beğenik H, Reha Erkoç, “Demographic and Clinical Characteristics of Familial Mediterranean Fever Cases in and Around Van ”National Rheumatology Congress, (PS-041) 31 October-3 November 2004, Antalya.
  • Sayarlıoğlu M, Çefle A, Beğenik H, Demirok A, “Rheumatologic Evaluation of Patients with Uveitis Ulusal, National Congress of Rheumatology, (PS-047), 31 October-3 November 2004, Antalya.
  • Harman E, Sayarlıoğlu M, Demir C, Sayarlıoğlu H, Çalka Ö, Akdeniz N, Sonat Kara P, Harman M. Evaluation of Coagulation Parameters in Behcet 's Patients. National Rheumatology Congress, 30 August-4 September 2005, Konya.
  • Çekici S, Sayarlıoğlu M, Sayarlıoğlu H, Ceylan K, Sonat Kara P, Doğan E, Erkoç R. Evaluation of Renal Function in Patients with Rheumatoid Arthritis. National Rheumatology Congress, 30 August-4 September 2005, Konya.
  • Mehmet Sayarlıoğlu,Ece Harman,Saliha Çekici,Hayriye Sayarlıoğlu,Pınar Sonat Kara. Demographic, Clinical and Treatment Characteristics of Behçet's Patients Living in and Around Van, National Internal Diseases Congress 2005, Antalya (Acceptance Letter)
  • Sayarlioglu H, Erkoc R, Etlik O, Sayarlioglu M, Dogan E, Esen R The Effect of Liver Fatty and Lipid Profile on Patients Undergoing Continuous Ambulatory Peritoneal Dialysis, 7th National Internal Diseases Congress 2005, Antalya (Accepted Letter)
  • Hayriye Sayarlıoğlu, Mehmet Sayarlıoğlu, Saliha Çekici, Pınar Sonat Kara, Haluk Dülger, Reha Erkoç Evaluation of Renal Function in Behcet's Disease, 7th National Internal Medicine Congress 2005, Antalya (Acceptance Letter)
  • Cefle A, Eminler AT, Sayarlioglu M. Adult Still Disease: Evaluation of 15 cases. National Rheumatology Congress, (PS-052), 31 October-3 November 2004, Antalya.
  • Inanc M, SİSVOÇ working group. Systemic sclerosis database creation (SISVOC-SISDC): Clinical features, disease activity, disease severity and loss of function. National Rheumatology Congress 2008, S: 0013, Antalya
  • Sayarlıoğlu M, Şahin M, Yıldırım Çetin G, Avan R, Cerit M. Still suffering from leflunomide and methotrexate in the first months of pregnancy. National Rheumatology Congress 2009, P84, Antalya
  • Gişi K, Köksal N, Sayarlıoğlu M, Çıralık H, Köroğlu S.   A case of rhabdomyolysis mimicking inflammatory myositis and caused by an electrical blanket. National Rheumatology Congress 2009, P26, Antalya
  • Çefle A, Sayarlıoğlu M, Kamalı S, Yazıcı A, İnanç M, Aral O Comparison of clinical and laboratory findings of 55 male patients with systemic lupus erythematosus. National Rheumatology Congress 2009, P010, Antalya
  • Sayarlıoğlu M, Yüzbaşıoğlu N, İnanç M, and friends The relationship between the development of avascular necrosis in patients with systemic lupus erythematosus and demographic, clinical, laboratory and treatment characteristics. National Rheumatology Congress 2009, P008, Antalya
  • Öztürk MA, Kaya A, Pehlivan Y, Kısacık B, Onat AM, Ugan Y, Tunç ŞE, Erhan Ç, Sayarlıoğlu M, and friends Demographic and clinical characteristics of gout patients in Turkey: a multicenter study. National Congress of Rheumatology in 2010, P076 118, Antalya
  • Onat AM, Turkbeyler IH, Pehlivan Y, Demir T, kaplan DS, Çeribaşı AO, Tutar E, taysi S, Kısacık B, Sayarlıoğlu M. Urotensin-II antagonism in the treatment of pulmonary hypertension: Palosuran. National Rheumatology Congress 2010: S4, Antalya
  • Gerdan V, Akar S, Pehlivan Y, Onat M, Solmaz D, Sayarlıoğlu M, Kısacık B, Erhan Ç and friends. Initial diagnosis of lumbar disc herniation in patients with ankylosing spondylitis is associated with delayed admission to the rheumatologist and delayed diagnosis. National Rheumatology Congress 2010: S6, Antalya
  • Pehlivan Y, Göğebakan B, Öztuzcu S, Özgen M, Yıldırım-Cetin GY, Cengiz B, Kısacık B, Koca SS, pamuk ÖN, Sayarlıoğlu M, Demiryürek AT, Onat AM. The relationship between systemic sclerosis and urotensin-II gene T21M and S89N polymorphism. National Rheumatology Congress 2010, P027, Antalya
  • Uçar MA, Yıldırım Çetin Y, Pehlivan Y, Özer A, Sayarlıoğlu H, Cerit M, Avan R, Şahin M, Kısacık B, Onat AM, Sayarlıoğlu M. The effect of anti-TNF drug use on the development of urinary infection in patients with rheumatoid arthritis and ankylosing spondylitis: a prospective cohort study. National Rheumatology Congress 2010, P007, Antalya
  • Sayarlıoğlu M, Yıldırım Çetin G, Pehlivan Y, and friends The relationship between skin pathergy test positivity and demographic, clinical, laboratory findings, disease activity and treatment in patients with Behcet 's disease. National Rheumatology Congress 2010, P058, Antalya
  •  Zeliha Yarar, Osman Cüre , Lütfi Akyol, Metin Özgen , Mehmet Sayarlıoğlu. Evaluation of late-onset ankylosing spondylitis patients, 2015 National Rheumatology Congress. October 2015 RAED proceedings book. PS-270 E-57-
  • Bünyamin Kısacık, Serdar Öztuzcu, Mustafa Ulaşlı ve arkadaşları. Frequency of HLA-B subtypes in anti-TNF-associated tuberculosis, 2015 National Rheumatology Congress. October 2015 RAED proceedings book. PS-040
  • Mehmet Akif Öztürk, Rıdvan Mercan, Kevser Gök ve ark. Treatment of different expertise in the treatment of gout in Turkey. Patient based questionnaire survey study, 2015 National Rheumatology Congress. October 2015 RAED proceedings book. PT-23
  • Lütfi Akyol , Bahtiyar Toz , Özün Bayndır and friends Behçet's disease and Budd-Chiari syndrome: Retrospective multicenter study. 2015 National Rheumatology Congress. October 2015 RAED proceedings book. SS-09
  • Umut Kalyoncu, Özün Bayındır, Mustafa Ferhat Öksüz adn friends Comorbidities in patients with psoriatic arthritis: Training is essential !. 2015 National Rheumatology Congress. October 2015 RAED proceedings book. SS-21
  • Umut Kalyoncu, Dilek Solmaz, Hakan Emmungil and fri. There is a correlation between Yamaguchi criterion score and clinical, laboratory findings of adult Still's disease and the doctor's initial treatment decision. 2015 National Rheumatology Congress. October 2015 RAED proceedings book. 2015 SS-01
  • Umut Kalyoncu, Özün Bayındır, Mustafa Ferhat Öksüz   and fri. General features of psoriatic arthritis cohort: 28 centers, results of 1081 patients, 2015 National Rheumatology Congress. October 2015 RAED proceedings book. 2015 SS-06
  • Umut Kalyoncu, Özün Bayındır, Mustafa Ferhat Öksüz. The first preferred DMARD in patients with psoriatic arthritis; Results of 909 patients from 28 centers. 2015 National Rheumatology Congress. October 2015 RAED proceedings book. SS-07
  • Fatma Alibaz Öner, Ali Uğur Ünal, Ahmet Mesut Onat, and fri. Takayasu's cohort of perception: Early disease is characterized by systemic inflammation. 2016 National Rheumatology Congress. October 2016 RAED magazine. SS19- Oral presentation.
  • Servet Akar, Pınar Çetin, Umut Kalyoncu and fri. Our national experience of IL-1 targeted therapies in familial Mediterranean fever. 2016 National Rheumatology Congress. October 2016 RAED magazine. PS-044
  • Nazife Şule Yaşar Bilge, İsmail Sarı, Dilek Solmaz and fri. Can age in familial Mediterranean fever affect the course of the disease? 2017 National Rheumatology Congress. October 2017 RAED magazine. PS-018
  • Nazife Şule Yaşar Bilge, İsmail Sarı, Dilek Solmaz and fri. Is the MEFV gene mutation in exon 2 or 10 effective in the clinical course of familial Mediterranean fever patients? 2017 National Rheumatology Congress. October 2017 RAED magazine. PS-019
  •  
  • Turkish Internal Medicine Specialty Association
  • Turkey Rheumatology Association

Book translations:

  • Soy M, editor. Harrison Rheumatology. Chapter 5: Rheumatoid arthritis (Peter E. Lipsky). Pages: 85-104
  • Kumar P, Clark M, editors. Clinical Medicine. Rheumatology and bone diseases. Pages 529-601.

Administrative Duties:

  • 2002-2003 Yüzüncü Yıl University Faculty of Medicine, Deputy Chief Physician
  • 2001-2005 Yüzüncü Yıl University Faculty of Medicine Chief Physician Department of Rheumatology
  • 2005-2013 Kahramanmaraş Sütçü Imam University Faculty of Medicine Chief Physician Department of Rheumatology
  • 2005-2011 Kahramanmaraş Sütçü Imam University Faculty of Medicine Chief Physician Department of Rheumatology
  • 2010-2011 Kahramanmaraş Sütçü Imam University Faculty of Medicine, Medicine Chief Physician Department of Internal Medical Sciences
  • 2013-2017 Ondokuz Mayıs University Faculty of Medicine Chief Physician Department of Rheumatology
  • 20013-2015 Board Member Director of Turkey Rheumatology Association 

Awards:

  • 2002 National Rheumatology Congress, Best Scientific Study Award (1-5 October 2002 Adana)Sayarlıoğlu M, Kamalı S, İnanç M, Ocal L, Aral O, Koniçe M, Gül A, ‘Minimal Determination of the minimal dose of erythema producing ultraviolet B in Behçet's disease and its comparison with skin pathergy test’ ’National Rheumatology Congress, 12, SB21, Adana, (2002).
  • 2004 National Rheumatology Congress, Young Scientist-Best scientific rheumatology article award (31 October-3 November 2004, Antalya) '' Tuberculosis in Turkish Patients with Systemic Lupus Erythematosus: Increased Frequency of Extrapulmonary Localization '' Lupus, 13, 274 -78 (2004).
  • 2010 National Rheumatology Congress Pfizer Ankylosing spondylitis award Gerdan V, Akar S, Pehlivan Y, Onat M, Solmaz D, Sayarlıoğlu M, Kısacık B, Erhan Ç Initial diagnosis of lumbar disc herniation in patients with ankylosing spondylitis is associated with delayed admission to the rheumatologist and delayed diagnosis. National Rheumatology Congress 2010: S6, Antalya

Ask Liv Expert